Abstract
Intravenous brentuximab vedotin (ADCETRIS((R))) is a targeted antibody-drug conjugate (ADC) active against CD30-positive cancer cells such as those as......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
